Wyeth is cutting back on drug rep visits to physician offices
“Wyeth spokesman Doug Petkus said his company is cutting back on repeat visits to the same general practitioners and internists because of the costs and also the growing unwillingness of busy doctors to endure so many sales calls.”
Related posts:
- Think the physician-pharma relationship is bad here?
- How much does a drug rep cost?
- Selling drug samples
- Drug reps are suing their employers
- Pristiq
- Dropping Medicare patients
- Drug reps getting cranky
KevinMD.com on Facebook
{ 2 comments }
The NYT reported Wyeth will cut 750 jobs and switch some full-times to part-time:
http://www.nytimes.com/2005/06/21/business/21wyeth.html
I’d like to hear what primary care physicians have to say about Wyeth’s “first to admit” stance that there are just too many pharmaceutical sales representatives. Do you think you will more likely see a rep that is the organization’s only rep that calls on you, or are you more likely to see more Pfizer reps, who have 6-8 individuals that may call on you?
Comments on this entry are closed.